Clinical Trial Update: Study Evaluating TCH346 and Placebo Administered Once Daily in Patients With Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study evaluating TCH346 versus placebo in amyotrophic lateral sclerosis that has completed. The study involved once…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• TCH346 (TCH-346)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED